Newsroom

Sorted by: Latest

-

Health Optimization & Longevity Arrives in Boulder: Next Health Celebrates Grand Opening with Live Podcast Recording Featuring Dr. Darshan Shah and Ben Greenfield

BOULDER, Colo.--(BUSINESS WIRE)--Next Health celebrates its grand opening in Boulder, Colorado with a live EXTEND Podcast recording featuring Dr. Darshan Shah and Ben Greenfield....
-

KBRA Assigns Preliminary Ratings to OBX 2026-AHC4 Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 64 classes of mortgage pass-through notes from OBX 2026-AHC4 Trust, a prime agency-eligible RMBS transaction sponsored by Onslow Bay Financial LLC, that is fully originated and serviced by AmeriHome Mortgage Company, LLC (AmeriHome). This transaction is comprised of 626 residential mortgages with an aggregate unpaid principal balance (UPB) of approximately $342.7 million as of the August 1, 2026 cut-off date. The underlying collater...
-

Nu Holdings Ltd. Reports Second Quarter 2026 Financial Results

SÃO PAULO--(BUSINESS WIRE)--Nu Holdings Ltd. (NYSE: NU) (“Nu” or the “Company”), the largest digital bank in Latin America, today released its financial results for the second quarter ended June 30, 2026, prepared in accordance with IFRS, as well as complementary managerial results. The financial statements and earnings presentation are available on the Company’s Investor Relations website at www.investors.nu, along with details of the earnings conference call to be held today at 6:00 p.m. East...
-

flyExclusive Reports Record Second Quarter Revenue and Third Consecutive Quarter of Positive Adjusted EBITDA

RALEIGH, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSE American: FLYX), a leading provider of premium private jet experiences, yesterday reported financial results for the second quarter and first half ended June 30, 2026. The Company generated record second-quarter revenue of $111.1 million, up 22% year over year, and its third consecutive quarter of positive Adjusted EBITDA, producing more revenue from a smaller, more productive fleet. The Company achieved those results with 6% fewer aircra...
-

Gold Reserve Announces Intention to Make Further CVR/Bonus Settlement Offers, to Make Offers to Optionholders, and to Amend Equity Incentive Plan

PEMBROKE, Bermuda--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announced today that it intends to make further offers to holders of its outstanding contingent value rights (“CVRs”) and to participants in its 2012 bonus plan (“Bonus Plan”) to settle such entitlements. The proposed settlement offers are expected to be made on substantially the same terms as the settlement offers previously made by the Company to CVR holders and Bo...
-

VerticalScope Announces Second Quarter 2026 Financial Results

TORONTO--(BUSINESS WIRE)--VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF), a technology company that has built and operates a cloud-based digital platform for online enthusiast communities, today announced financial results for the second quarter ended June 30, 2026 ("Q2" or "the quarter"). "Q2 delivered the gains we've been building toward and marked a turning point," said Chris Goodridge, CEO of VerticalScope. "Revenue grew 20% over Q1, which outpaced...
-

Franklin BSP Capital Corporation Announces Third Quarter 2026 Dividend

NEW YORK--(BUSINESS WIRE)--Franklin BSP Capital Corporation (“FBCC” or the “Company”) announced its Board of Directors has declared a third quarter 2026 cash distribution of $0.24 per common share. The distribution is payable on or about September 30, 2026 to common stockholders of record as of September 24, 2026. The Board of Directors has also declared a corresponding third quarter 2026 cash distribution on its convertible Series A Preferred Stock in an amount equal to the as-converted common...
-

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS...
-

AS Watson Expands Partnership With NCR Voyix Through Global Voyix Commerce Platform Agreement

ATLANTA--(BUSINESS WIRE)--NCR Voyix (NYSE: VYX), a platform-powered leader in unified commerce for shopping and dining, today announced a new multi-year enterprise agreement with AS Watson, the world’s largest international health and beauty retailer, to expand their technology partnership. Under the agreement, AS Watson will adopt the Voyix Commerce Platform, deploying Voyix POS, self-checkout, loyalty and managed services across select retail brands and markets in Europe and Asia, including W...
-

Mativ Announces Participation in Upcoming Investor Conferences

ALPHARETTA, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (NYSE: MATV) today announced its participation in the following upcoming investor conferences: Seaport Research Partners Annual Summer Investor Conference (Virtual) – August 18, 2026 Sidoti Small-Cap Virtual Investor Conference – September 23, 2026 Thank you for your interest in Mativ. We look forward to your participation in the conferences. About Mativ Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers’...